Vitiligo in an Italian outpatient center: A clinical and serologic study of 204 patients in Tuscany

American Journal of Clinical Dermatology

Volumn 12, Issue 1, 2011, Pages 43-49

  Berti, Samantha ^a   Bellandi, Serena ^a   Bertelli, Antonella ^b   Colucci, Roberta ^a   Lotti, Torello ^a   Moretti, Silvia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Adults; Antinuclear antibodies; Autoantibodies; Autoimmune disorders; Children; HLA antigens; Vitiligo, epidemiology

Indexed keywords

AUTOANTIBODY; COMPLEMENT; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HALO NEVUS; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SEROLOGY; SEX RATIO; SKIN ALLERGY; UNIVERSITY HOSPITAL; VITILIGO;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HLA ANTIGENS; HUMANS; ITALY; MALE; NEVUS, HALO; OUTPATIENTS; SEX DISTRIBUTION; VITILIGO;

EID: 78649675866     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11537090-000000000-00000     Document Type: Article

References (29)

1. Ortonne JP, Moscher DB, Fitzpatrick TB. Hypomelanotic disorders in vitiligo and other hypomelanoses of hair and skin. New York: Plenum, 1983: 129-310
2. Hann S-K, Nordlund J. Vitiligo. Oxford: Blackwell Science, 2000
3. Howitz J, Brodthagen H, Schwartz M, et al. Prevalence of vitiligo: epidemio-logic survey onthe IsleofBorholm, Denmark. Arch Dermatol 1977; 113: 47-52
4. Mehta NR, Shan KC, Theodore C, et al. Epidemiological study of vitiligo in Surat area. Indian J Med Res 1973; 61: 145-54
5. Carnevale A, Zavala C, Castillo VD, et al. Genetic analysis of 127 families with vitiligo [in Spanish]. Rev Invest Clin 1980; 32: 37-41
6. Hafez M, Sharaf L, El-Nabi SMA. The genetics of vitiligo. Acta Dermatovener (Stockh) 1983; 63: 249-51
7. Das SK, Majumdear PP, Chakraborty R, et al. Studies on vitiligo: I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985; 2: 71-8
8. Das SK, Majumder PP, Majumder TK, et al. Studies on vitiligo: II. Familial aggregation and genetics. Genet Epidemiol 1985; 2: 255-62
9. Majumder PP, Das SK, Li CC. Agenetical model for vitiligo. Am J Hum Genet 1988; 43: 119-25
10. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol 1993; 129: 994-8
11. Schallreuter KU, Lemke R, Brandt O, et al. Vitiligo and other disease: co-existence or true association? Dermatology 1994; 188: 269-75
12. Nordlund JJ, Lerner AB. Vitiligo: it is important. Arch Dermatol 1982; 118: 5-8
13. Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988; 118: 223-8
14. Orecchia G, Perfetti L, Malagoli P, et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and decrease in C4AQO in northern Italian patients. Dermatology 1992; 185: 123-7
15. Liu JB, Li M, Yang S, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 2005; 30: 327-31
16. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208-14
17. Onunu AN, Kubeyinje EP. Vitiligo in Nigerian African: a study of 351 patients in Benin City, Nigeria. Int J Dermatol 2003; 42: 800-2
18. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005; 18: 300-5
19. Hegedus L, Heidenheim M, Gervil M, et al. High frequency of thyroid dys-function in patients with vitiligo. Acta Derm Venereol 1994; 74: 120-3
20. Betterle C, Carretto A, De Zio A, et al. Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 1985; 171: 419-23
21. Zamani M, Spaepen M, Sghar SS, et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 2001; 145: 90-4
22. Liu JB, Li M, Chen H, et al. Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 2007; 21: 205-13
23. Abanmi A, Harthi FA, Baqami RA, et al. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch Dermatol Res 2006; 298: 347-52
24. Xia Q, Zhou WM, Liang YH, et al. MHC haplotypic association in Chinese Han patients with vitiligo. J Eur J Dermatol Venereol 2006; 20: 941-6
25. Tastan HB, Akar A, Orkunoglu FE, et al. Association of HLA class I antigens and HLA class II antigens with vitiligo in a Turkish population. Pigment Cell Res 2004; 17: 181-4
26. Ando I, Chi H, Nakagawa H, et al. Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol 1993; 129: 408-10
27. de Vijlder HC, Westerhof W, Schreuder GM, et al. Difference in pathogenesis between vitiligo vulgaris and halo nevi associate with vitiligo is supported by an HLA association study. Pigment Cell Res 2004; 17: 270-4
28. Hu Z, Liu JB, Ma SS, et al. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol 2006; 23: 114-6
29. Finco O, Cuccia M, Martinetti M, et al. Age of onset in vitiligo: relationship with HLA supratypes. Clin Genet 1991; 39: 48-54